Defense Medical Research and Development

Each of these major research program areas is strategically guided by a committee, called a Joint Program Committee, or JPC, which consists of Department of Defense (DoD) and non-DoD medical and military technical experts. These experts work through coordinated efforts to translate guidance into research and development needs. They also have key responsibilities for making funding recommendations and providing program management support. Within the USAMRMC, operational support for the JPCs is provided by multiple execution agents, including the CDMRP, individual laboratories, and advanced developers. CDMRP provides program and award management support primarily for basic through translational research (Program Elements 6.1 through 6.3) and also works closely with the JPCs to transition products to advanced development.
CDMRP-Managed Congressional Appropriations
- $815.7 million
FY10-18 - $90.2 million
FY19 (estimate)
Peer Review
Participants
Joint Program
Committee
- Medical Simulation and Information Sciences Research Program (JPC-1)
- Military Infectious Diseases Research Program (JPC-2)
- Military Operational Medicine Research Program (JPC-5)
- Combat Casualty Care Research Program (JPC-6)
- Radiation Health Effects Research Program (JPC-7)
- Clinical and Rehabilitative Medicine Research Program (JPC-8)
Last updated Wednesday, February 19, 2025